Authors: Mazurier, C Goudemand, J Hilbert, L Caron, C Fressinaud, E Meyer, D

Citation: C. Mazurier et al., Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology, BEST P R C, 14(2), 2001, pp. 337-347

Authors: Meyer, D Fressinaud, E Hilbert, L Ribba, AS Lavergne, JM Mazurier, C

Citation: D. Meyer et al., Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function, BEST P R C, 14(2), 2001, pp. 349-364

Authors: Goodeve, AC Eikenboom, JCJ Ginsburg, D Hilbert, L Mazurier, C Peake, IR Sadler, JE Rodeghiero, F

Citation: Ac. Goodeve et al., A standard nomenclature for von Willebrand factor gene mutations and polymorphisms, THROMB HAEM, 85(5), 2001, pp. 929-931

Authors: Ribba, AS Hilbert, L Lavergne, JM Fressinaud, E Boyer-Neumann, C Ternisien, C Juhan-Vague, I Goudemand, J Girma, JP Mazurier, C Meyer, D

Citation: As. Ribba et al., The arginine-552-cysteine (R1315C) mutation within the Al loop of von Willebrand factor induces an abnormal folding with a loss of function resultingin type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor, BLOOD, 97(4), 2001, pp. 952-959

Authors: Hilbert, L Jenkins, PV Gaucher, C Meriane, E Collins, PW Pasi, KJ Mazurier, C

Citation: L. Hilbert et al., Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor, THROMB HAEM, 84(2), 2000, pp. 188-194

Authors: Hilbert, L Gaucher, C Abgrall, JF Parquet, A Trzeciak, C Mazurier, C

Citation: L. Hilbert et al., Identification of new type 2B von Willebrand disease mutations: Arg543Gln,Arg545Pro and Arg578Leu, BR J HAEM, 103(3), 1998, pp. 877-884